UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder

PloS one, 2013-05, Vol.8 (5), p.e63023

2013

Volltextzugriff (PDF)

Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth

Current pharmaceutical design, 2010-07, Vol.16 (22), p.2416-2423

2010

Volltextzugriff (PDF)

Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine

Journal of the American Academy of Child and Adolescent Psychiatry, 2017-07, Vol.56 (7), p.602-609.e2

2017

Volltextzugriff (PDF)

Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder

The Pediatric clinics of North America, 2011-02, Vol.58 (1), p.99-120

2011

Volltextzugriff (PDF)

Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment

Journal of the American Academy of Child and Adolescent Psychiatry, 2009-05, Vol.48 (5), p.501-510

2009

Volltextzugriff (PDF)

A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD)

CNS drugs, 2021-10, Vol.35 (10), p.1035-1051

2021

Volltextzugriff (PDF)

Randomized, Double-Blind Trial of Guanfacine Extended Release in Children With Attention-Deficit/Hyperactivity Disorder: Morning or Evening Administration

Journal of the American Academy of Child and Adolescent Psychiatry, 2013-09, Vol.52 (9), p.921-930

2013

Volltextzugriff (PDF)

Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents

Journal of child and adolescent psychopharmacology, 2012-06, Vol.22 (3), p.238-244

2012

Volltextzugriff (PDF)

Clinical Responses to Atomoxetine in Attention-Deficit/Hyperactivity Disorder: The Integrated Data Exploratory Analysis (IDEA) Study

Journal of the American Academy of Child and Adolescent Psychiatry, 2009-05, Vol.48 (5), p.511-518

2009

Volltextzugriff (PDF)

Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence

Neuroscience and biobehavioral reviews, 2022-04, Vol.135, p.104575-104575, Article 104575

2022

Volltextzugriff (PDF)

Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis

Molecular psychiatry, 2022-01, Vol.27 (1), p.212-219

2022

Volltextzugriff (PDF)

Nonstimulant Treatments for ADHD

Child and adolescent psychiatric clinics of North America, 2022-07, Vol.31 (3), p.417-435

2022

Volltextzugriff (PDF)

Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status

CNS drugs, 2021-06, Vol.35 (6), p.643-653

2021

Volltextzugriff (PDF)

So What Really Is New in the Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder?

Child and adolescent psychiatric clinics of North America, 2022-07, Vol.31 (3), p.xiii-xiv

2022

Volltextzugriff (PDF)

Characteristics of Placebo Responders in Pediatric Clinical Trials of Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child and Adolescent Psychiatry, 2009-12, Vol.48 (12), p.1165-1172

2009

Volltextzugriff (PDF)

The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

Journal of the American Academy of Child and Adolescent Psychiatry, 2009-05, Vol.48 (5), p.484-500

2009

Volltextzugriff (PDF)

Long-Term Treatment With Extended-Release Methylphenidate Treatment in Children Aged 4 to <6 Years

Journal of the American Academy of Child and Adolescent Psychiatry, 2022-01, Vol.61 (1), p.80-92

2022

Volltextzugriff (PDF)

Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder

The Journal of neuroscience, 2012-01, Vol.32 (3), p.841-849

2012

Volltextzugriff (PDF)

Effects of Stimulant Treatment on Changes in Brain Activation During Reward Notifications in Drug Naïve Youth With ADHD

Journal of attention disorders, 2024-03, Vol.28 (5), p.847-860

2024

Volltextzugriff (PDF)

A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD)

CNS drugs, 2018-03, Vol.32 (3), p.289-301

2018

Volltextzugriff (PDF)

Neurobiological basis of reinforcement-based decision making in adults with ADHD treated with lisdexamfetamine dimesylate: Preliminary findings and implications for mechanisms influencing clinical improvement

Journal of psychiatric research, 2024-02, Vol.170, p.19-26

2024

Volltextzugriff (PDF)

A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders

Journal of child and adolescent psychopharmacology, 2013-06, Vol.23 (5), p.308

2013

Volltextzugriff (PDF)

A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults

Clinical therapeutics, 2017-08, Vol.39 (8), p.1695-1705

2017

Volltextzugriff (PDF)

Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study

Journal of child psychology and psychiatry, 2016-06, Vol.57 (6), p.717-728

2016

Volltextzugriff (PDF)

Effect of Two Different Methods of Initiating Atomoxetine on the Adverse Event Profile of Atomoxetine

Journal of the American Academy of Child and Adolescent Psychiatry, 2007-05, Vol.46 (5), p.566-572

2007

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Aktive Filter

ThemaAttention Deficit Disorder With Hyperactivity - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(89)

Sprache

Englisch
(89)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(89)
Science & Technology
(72)
Life Sciences & Biomedicine
(71)
Child
(63)
Psychiatry
(63)
Male
(57)
Female
(56)
Attention Deficit Hyperactivity Disorder
(50)
Adolescent
(44)
Central Nervous System Stimulants - Therapeutic Use
(40)
Pediatrics
(37)
Psychology
(37)
Social Sciences
(37)
Psychology, Developmental
(31)
Drug Therapy
(30)
Treatment Outcome
(30)
Hyperactivity
(28)
Double-Blind Method
(27)
Biological And Medical Sciences
(25)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder

Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth

Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine

Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder

Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment

A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD)

Randomized, Double-Blind Trial of Guanfacine Extended Release in Children With Attention-Deficit/Hyperactivity Disorder: Morning or Evening Administration

Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents

Clinical Responses to Atomoxetine in Attention-Deficit/Hyperactivity Disorder: The Integrated Data Exploratory Analysis (IDEA) Study

Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence

Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis

Nonstimulant Treatments for ADHD

Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status

So What Really Is New in the Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder?

Characteristics of Placebo Responders in Pediatric Clinical Trials of Attention-Deficit/Hyperactivity Disorder

The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

Long-Term Treatment With Extended-Release Methylphenidate Treatment in Children Aged 4 to <6 Years

Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder

Effects of Stimulant Treatment on Changes in Brain Activation During Reward Notifications in Drug Naïve Youth With ADHD

A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD)

Neurobiological basis of reinforcement-based decision making in adults with ADHD treated with lisdexamfetamine dimesylate: Preliminary findings and implications for mechanisms influencing clinical improvement

A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders

A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults

Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study

Effect of Two Different Methods of Initiating Atomoxetine on the Adverse Event Profile of Atomoxetine

Aktive Filter

Suchergebnisse filtern